Clinical Trial Update: Bevacizumab And Combination Chemotherapy in Rectal Cancer Until Surgery [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating bevacizumab with combination chemotherapy in rectal cancer until surgery has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: University College, London | Conditions: Rectal Cancer | Phase 2 | Status: COMPLETED